Financial Management Professionals’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5K Buy
281
+41
+17% +$1.76K ﹤0.01% 536
2026
Q1
$9.11K Sell
240
-169
-41% -$8.01K ﹤0.01% 549
2025
Q4
$20.8K Sell
409
-128
-24% -$6.54K ﹤0.01% 399
2025
Q3
$29.8K Sell
537
-87
-14% -$5.09K ﹤0.01% 314
2025
Q2
$43.1K Buy
624
+76
+14% +$5.17K ﹤0.01% 272
2025
Q1
$38.1K Sell
548
-254
-32% -$21K ﹤0.01% 301
2024
Q4
$69K Buy
802
+96
+14% +$10.4K 0.01% 231
2024
Q3
$84K Sell
706
-747
-51% -$99.6K 0.01% 206
2024
Q2
$207K Buy
1,453
+742
+104% +$98.3K 0.03% 140
2024
Q1
$91K Buy
711
+199
+39% +$23.7K 0.01% 210
2023
Q4
$53K Buy
512
+8
+2% +$791 0.01% 254
2023
Q3
$46K Sell
504
-42
-8% -$3.7K 0.01% 255
2023
Q2
$44K Sell
546
-56
-9% -$4.58K 0.01% 272
2023
Q1
$48K Buy
602
+130
+28% +$9.22K 0.01% 279
2022
Q4
$32K Sell
472
-152
-24% -$8.91K 0.01% 282
2022
Q3
$31K Buy
624
+304
+95% +$16.3K 0.01% 270
2022
Q2
$18K Buy
320
+94
+42% +$5.22K ﹤0.01% 376
2022
Q1
$13K Sell
226
-76
-25% -$3.9K ﹤0.01% 467
2021
Q4
$17K Buy
302
+38
+14% +$2.06K ﹤0.01% 361
2021
Q3
$13K Buy
264
+146
+124% +$7.06K ﹤0.01% 427
2021
Q2
$5K Hold
118
﹤0.01% 524
2021
Q1
$4K Buy
118
+48
+69% +$1.71K ﹤0.01% 505
2020
Q4
$2K Buy
70
+16
+30% +$553 ﹤0.01% 561
2020
Q3
$2K Hold
54
﹤0.01% 520
2020
Q2
$2K Buy
+54
New +$1.72K ﹤0.01% 511

Other funds holding NVO

Financial Management Professionals's NVO Position: Q2 2026 in Review

Financial Management Professionals increased its Novo Nordisk (NVO) stake by 17% in Q2 2026, buying an estimated $1.76K and bringing the position to 281 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

Financial Management Professionals first reported a position in NVO in Q2 2020 and has held it in 25 quarters since. The position peaked at $207K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Financial Management Professionals held 281 shares of Novo Nordisk worth $13.5K as of Q2 2026.
  • Financial Management Professionals bought 41 Novo Nordisk shares in Q2 2026, an estimated $1.76K.
  • Novo Nordisk made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #536 holding.
  • Financial Management Professionals first reported a position in Novo Nordisk in Q2 2020 and has held it in 25 quarters since.
  • Financial Management Professionals's Novo Nordisk position peaked at $207K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.